Tuesday - February 3, 2026
University of Eastern Finland: Cholesterol-lowering Drug Evolocumab Significantly Reduces the Risk of a First Cardiovascular
November 26, 2025
KUOPIO, Finland, Nov. 26 (TNSjou) -- The University of Eastern Finland issued the following news:

* * *

Cholesterol-lowering drug evolocumab significantly reduces the risk of a first cardiovascular

In a large international trial, the PCSK9 inhibitor evolocumab reduced the risk of a first cardiovascular event among high-risk patients without a previous myocardial infarction or stroke.

In Finland, the study was led by Professor Johanna Kuusisto a . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products